The Global Rise of the Laryngeal Mask : New Advancements in Clinical Adoption
![]() |
Laryngeal Mask |
The
laryngeal mask airway, commonly known as the LMATM, is a supraglottic airway
device that was invented by British anesthesiologist Dr. Archie Brain in 1981.
Since its introduction, it has gained widespread popularity and acceptance in
clinical practice across both developing and developed countries due to its
effectiveness and relative ease of use compared to conventional endotracheal
intubation. Some key facts about it include:
- It is inserted above the glottis instead of passing through the vocal cords
like an endotracheal tube. This makes it a useful and safer alternative to
endotracheal intubation in some clinical situations.
- Various sizes and models have been developed over the years to accommodate
patients of different ages and anatomy. This has expanded its clinical
applications.
- It helps maintain a clear Laryngeal
Mask and provides a channel through which gases can be delivered to the
lungs during general anesthesia or ventilation.
- Placement of the laryngeal mask is generally less technically demanding than
intubation and has a faster insertion time, lowering the risk of peri-operative
complications in some patients.
Widespread Clinical Adoption
Since the 1980s, use of the it has grown dramatically worldwide. Initial
skepticism from some in the anesthesia community was overcome as its safety
profile and utility became clear. Paired with international education and
training programs, it achieved recognition as an essential airway management
device. Some key developments in its global adoption include:
- By the 1990s it had become a standard of care in the UK and other developed
nations for many surgical procedures not requiring intubation. Regional and
national airway guidelines increasingly recommended its use over other
supplemental oxygenation methods in appropriate cases.
- Its lower technical demand and procurement cost made it appealing for
resource-limited settings. International organizations helped distribute
laryngeal masks and train local clinicians in the developing world.
- The 2000s saw a proliferation of new LMATM models. Products tailored for
pediatric and infant patients expanded its reach to those populations.
Disposable and single-use versions cut infection risks.
- Today it is regularly stocked in hospital pharmacies, on ambulances, and
other emergency contexts worldwide due to its versatility and ease of
deployment even by non-anesthesia staff. This has increased patient access to
safer airway management.
Global Adoption Statistics
Solid statistics on it use are difficult to obtain, but some figures indicate
the remarkable extent of its worldwide dispersion:
- A 2014 study analyzing sales records estimated over 150 million LMATM devices
have been sold to date across nearly 200 countries. While use remains highest
in wealthier nations, shipments have greatly increased to developing regions as
well.
- Surveys of anesthesia providers show it is routinely employed for many cases
in every continent except Antarctica. Reported usage rates range from 30-80% of
general surgical/procedural cases depending on the practice setting and
country.
- Sales of the classic reusable LMATM remain strong but single-use disposable
models now account for the bulk of the global market volume. Their convenience
and sterility make them preferred in many health systems.
- Developing world data indicate the laryngeal mask is employed as a primary
airway management strategy for millions of surgeries annually that otherwise
may have been postponed due to intubation challenges or costs. This improves
global surgical access.
Manufacturing and Innovation
The commercial success of the laryngeal mask has spurred growth in
manufacturing of these devices worldwide to meet rising demand. Great strides
have also been made across various models to enhance user experience:
- The dominant global supplier remains Intersurgical Ltd., created in 1989 and
headquartered in the UK, where Dr. Brain's original patents are licensed. It
produces several laryngeal mask brands at multiple international plants.
- However, numerous other medical firms now manufacture compatible 3rd-party
LMATM devices approved for clinical use. Major centers of production include
Europe, North America, India, China, and Indonesia.
- Advanced new versions continually debut with improved features. Examples
include masks with gastric access ports, integrated bite blocks, reinforced
tubes, enhanced cuffs for better seals, sizes for neonates, and devices
optimized for laparoscopic or airway exchange procedures.
- Select models offer multi-oriface design for simultaneous use with
nasogastric tubes or bronchoscopes. Some incorporate fiberoptic technology to
aid placement verification. Developments aim to support it being used in ever
more complex situations.
Future Outlook
Barring unexpected changes, laryngeal masks appear poised to maintain their
prominent role in global airway management. Key factors that may influence
their usage trends over the coming decades include:
- Continuing medical education efforts to optimize it techniques and expand
appropriate applications based on ongoing research findings.
- Further drops in device costs as production scales up, enhancing
accessibility in resource-limited settings and boosting sustained dissemination
worldwide.
- Innovation of next-generation variants optimized for specific clinical
contexts like resuscitation, bariatric/obese patients, or surgeries requiring
longer operative times.
- Potential incorporation of more digital technology aids like integrated
cameras, oxygen saturation monitoring, or disposable devices programmed with
usage data.
- Integration with bundled surgical packs and procedure toolkits to facilitate
"push" distribution models getting equipment where most needed, like
emergency and prehospital contexts.
Get More Insights on- Laryngeal Masks
About
Author:
Ravina
Pandya, Content
Writer, has a strong foothold in the market research industry. She specializes
in writing well-researched articles from different industries, including food
and beverages, information and technology, healthcare, chemical and materials,
etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment